Arcturus Therapeutics gains 5.8% on Thermo Fisher deal
Arcturus Therapeutics gains 5.8% on Thermo Fisher deal
Arcturus Therapeutics gains 5.8% on Thermo Fisher deal
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.